Carisma is headquartered in Philadelphia.
As part of the deal, Carisma will shift manufacturing to a Novartis cell therapy site in Morris Plains, New Jersey.
Novartis anticipates clinical manufacturing to begin in 2023.
Get the full story from our sister site, Drug Discovery & Development.
Tell Us What You Think!